Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 11:11 PM
NCT ID:
NCT04544293
Pre Assignment Details:
Two screening visits were conducted 6 and 3 weeks prior to the Day 1 baseline visit. At the baseline visit, eligible subjects were centrally randomized through a Randomization and Trial Supply Management system to 48 weeks of double-blind treatment with MOL-OD or PBO.
To be randomized patients were required to have a percent predicted DLCO adjusted for hemoglobin (%DLCOadj) of 70% or less and no variation in %DLCOadj of +/-15%.
Recruitment Details:
Outpatient Medical Clinics 19 May 2021 -16 June 2023
Study:
NCT04544293
Study Brief:
Results Section:
NCT04544293